{"id":"https://openalex.org/W2052900580","doi":"https://doi.org/10.1159/000139494","title":"Effect of Y-24180, a Long-Acting Antagonist to Platelet-Activating Factor (PAF), on PAF-lnduced Reactions: A Relationship between the Partial Structure of the Compound and Its Duration of the Action","display_name":"Effect of Y-24180, a Long-Acting Antagonist to Platelet-Activating Factor (PAF), on PAF-lnduced Reactions: A Relationship between the Partial Structure of the Compound and Its Duration of the Action","publication_year":2008,"publication_date":"2008-06-10","ids":{"openalex":"https://openalex.org/W2052900580","doi":"https://doi.org/10.1159/000139494","mag":"2052900580","pmid":"https://pubmed.ncbi.nlm.nih.gov/9380772"},"language":"en","primary_location":{"id":"doi:10.1159/000139494","doi":"https://doi.org/10.1159/000139494","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000139494","pdf_url":null,"source":{"id":"https://openalex.org/S106137443","display_name":"Pharmacology","issn_l":"0031-7012","issn":["0031-7012","1423-0313"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113543929","display_name":"Masahiko Kagoshima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masahiko Kagoshima","raw_affiliation_strings":["Research Laboratories, Yoshitomi Pharmaceutical Industries Ltd, Fukuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Yoshitomi Pharmaceutical Industries Ltd, Fukuoka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052039395","display_name":"Noriko Tomomatsu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Noriko Tomomatsu","raw_affiliation_strings":["Research Laboratories, Yoshitomi Pharmaceutical Industries Ltd, Fukuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Yoshitomi Pharmaceutical Industries Ltd, Fukuoka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113770250","display_name":"Yoshinori Iwahisa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshinori Iwahisa","raw_affiliation_strings":["Research Laboratories, Yoshitomi Pharmaceutical Industries Ltd, Fukuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Yoshitomi Pharmaceutical Industries Ltd, Fukuoka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107344233","display_name":"Shuji Yamaguchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shuji Yamaguchi","raw_affiliation_strings":["Research Laboratories, Yoshitomi Pharmaceutical Industries Ltd, Fukuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Yoshitomi Pharmaceutical Industries Ltd, Fukuoka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110101369","display_name":"Yukio Kawakami.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yukio Kawakami.","raw_affiliation_strings":["Research Laboratories, Yoshitomi Pharmaceutical Industries Ltd, Fukuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Yoshitomi Pharmaceutical Industries Ltd, Fukuoka, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028313472","display_name":"Michio Terasawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michio Terasawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.287,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.69142413,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"54","issue":"5","first_page":"261","last_page":"270"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/platelet-activating-factor-antagonist","display_name":"platelet-activating factor antagonist","score":0.9110000133514404},{"id":"https://openalex.org/keywords/paf-receptor","display_name":"PAF receptor","score":0.6990000009536743},{"id":"https://openalex.org/keywords/web-2086","display_name":"WEB 2086","score":0.8809999823570251},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7609999775886536},{"id":"https://openalex.org/keywords/duration-of-action","display_name":"duration of action","score":0.7689999938011169},{"id":"https://openalex.org/keywords/bronchoconstriction","display_name":"bronchoconstriction","score":0.9359999895095825},{"id":"https://openalex.org/keywords/airway-hyperresponsiveness","display_name":"airway hyperresponsiveness","score":0.9950000047683716},{"id":"https://openalex.org/keywords/platelet-aggregation","display_name":"platelet aggregation","score":0.9350000023841858},{"id":"https://openalex.org/keywords/thienodiazepines","display_name":"thienodiazepines","score":0.7459999918937683},{"id":"https://openalex.org/keywords/guinea-pig","display_name":"guinea pig","score":0.4729999899864197}],"concepts":[{"id":"https://openalex.org/C2780769369","wikidata":"https://www.wikidata.org/wiki/Q4375","display_name":"Bronchoconstriction","level":3,"score":0.8858155012130737},{"id":"https://openalex.org/C2779020240","wikidata":"https://www.wikidata.org/wiki/Q420577","display_name":"Platelet-activating factor","level":2,"score":0.8362374305725098},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7323563694953918},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6288288831710815},{"id":"https://openalex.org/C2778689049","wikidata":"https://www.wikidata.org/wiki/Q898422","display_name":"Substituent","level":2,"score":0.5578389167785645},{"id":"https://openalex.org/C1122143","wikidata":"https://www.wikidata.org/wiki/Q61233","display_name":"Histamine","level":2,"score":0.4634627401828766},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4630795419216156},{"id":"https://openalex.org/C2777242621","wikidata":"https://www.wikidata.org/wiki/Q647917","display_name":"Leukotriene D4","level":4,"score":0.4421243667602539},{"id":"https://openalex.org/C2779591629","wikidata":"https://www.wikidata.org/wiki/Q24745328","display_name":"Bradykinin","level":3,"score":0.4340098202228546},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.411128431558609},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2958891689777374},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.19688427448272705},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19431555271148682},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1271292269229889},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.0788201093673706}],"mesh":[{"descriptor_ui":"D000109","descriptor_name":"Acetylcholine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000109","descriptor_name":"Acetylcholine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001920","descriptor_name":"Bradykinin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001920","descriptor_name":"Bradykinin","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006632","descriptor_name":"Histamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006632","descriptor_name":"Histamine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010972","descriptor_name":"Platelet Activating Factor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D010972","descriptor_name":"Platelet Activating Factor","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D010980","descriptor_name":"Platelet Membrane Glycoproteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011956","descriptor_name":"Receptors, Cell Surface","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D016084","descriptor_name":"Bronchoconstriction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016535","descriptor_name":"Bronchial Hyperreactivity","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D016535","descriptor_name":"Bronchial Hyperreactivity","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D017998","descriptor_name":"Leukotriene D4","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017998","descriptor_name":"Leukotriene D4","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D043562","descriptor_name":"Receptors, G-Protein-Coupled","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1159/000139494","doi":"https://doi.org/10.1159/000139494","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000139494","pdf_url":null,"source":{"id":"https://openalex.org/S106137443","display_name":"Pharmacology","issn_l":"0031-7012","issn":["0031-7012","1423-0313"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology","raw_type":"journal-article"},{"id":"pmid:9380772","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9380772","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2023594621","https://openalex.org/W1977296279","https://openalex.org/W1983741531","https://openalex.org/W2311742997","https://openalex.org/W2054632492","https://openalex.org/W2051157152","https://openalex.org/W2000769210","https://openalex.org/W2084700869","https://openalex.org/W1987264152","https://openalex.org/W1965870586"],"abstract_inverted_index":{"(+/-)-4-(2-Chlorophenyl)-2-[2-(4-isobutylphenyl)ethyl]-6,9-dime":[0],"thy":[1],"l-6H-":[2],"thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine":[3],"(Y-24180)":[4],"is":[5,26],"a":[6,30,137,160,171],"platelet-activating":[7],"factor":[8],"(PAF)":[9],"antagonist,":[10],"being":[11],"similar":[12],"to":[13,184],"WEB":[14,46,91,125,150],"2086.":[15,92],"One":[16],"of":[17,29,38,79,90,131,157,166,192,211],"the":[18,22,27,36,73,76,94,105,128,132,164,185,189,193,199,206,227,235],"structural":[19],"differences":[20],"between":[21],"two":[23],"PAF":[24,186,207,231],"antagonists":[25],"presence":[28],"methyl":[31,161],"substituent":[32,162,201],"in":[33,69,120,136,219,234],"Y-24180":[34,44,80,97,123,152,225],"at":[35],"6-position":[37,165],"its":[39,215],"ring":[40],"system.":[41],"Orally":[42],"administered":[43],"and":[45,56,61,65,85,124,142,149,153,179,229],"2086":[47,126],"both":[48,156],"dose-dependently":[49],"prevented":[50],"PAF-induced":[51,129,177],"airway":[52],"hyperresponsiveness":[53],"(ED50:":[54,63],"0.0010":[55],"0.019":[57],"mg/":[58],"kg,":[59],"respectively)":[60,68],"bronchoconstriction":[62,106,178],"0.0014":[64],"0.024":[66],"mg/kg,":[67,99],"guinea":[70],"pigs.":[71],"Against":[72],"bronchoconstriction,":[74],"here,":[75],"inhibitory":[77],"effect":[78,175],"was":[81],"significantly":[82,180],"more":[83,181],"potent":[84],"longer":[86,172],"acting":[87,173],"than":[88],"that":[89,224],"On":[93],"other":[95],"hand,":[96],"(10":[98],"p.o.)":[100],"showed":[101],"insignificant":[102],"effects":[103,218,233],"on":[104,163,176],"induced":[107],"by":[108],"leukotriene":[109],"D4,":[110],"histamine,":[111],"serotonin,":[112],"acetylcholine,":[113],"arachidonic":[114],"acid,":[115],"or":[116],"bradykinin.":[117],"In":[118],"an":[119],"vitro":[121],"test,":[122],"inhibited":[127],"aggregation":[130],"rabbit":[133],"washed":[134],"platelets":[135],"concentration-dependent":[138],"manner":[139],"(IC50:":[140],"1.2":[141],"64":[143],"nmol/l,":[144],"respectively).":[145],"Compared":[146],"with":[147],"desmethyl-Y-24180":[148],"2086,":[151,155],"methyl-WEB":[154],"which":[158],"have":[159],"their":[167],"thienodiazepine":[168],"ring,":[169],"exhibited":[170],"suppressive":[174],"stable":[182],"binding":[183,209],"receptor":[187,208],"after":[188],"washing-out":[190],"procedure":[191],"test":[194],"compounds":[195],"from":[196],"platelets.":[197],"Therefore,":[198],"6-methyl":[200],"should":[202],"be":[203],"responsible":[204],"for":[205,214],"stability":[210],"Y-24180,":[212],"namely,":[213],"long-acting":[216,230],"anti-PAF":[217],"vivo.":[220],"These":[221],"results":[222],"indicate":[223],"possesses":[226],"specific":[228],"antagonistic":[232],"airway.":[236]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}